P.655 Resilience and emotional state of healthcare professionals in Ukraine during lockdown: a pilot study

Khaustova, Olena; Чабан, Олег; Assonov, Dmytro

doi:10.1016/j.euroneuro.2020.09.480

Cited by 2 publications

(3 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study was conducted during the peak of the second wave of the COVID-19 pandemic in the country, which was characterized by the placing of a critical load on the medical infrastructure and health care staff. To our knowledge, the only other study that previously assessed the psychological impact of COVID-19 on medical workers was conducted in Ukraine [ 20 ]. However, it involved a relatively small sample size and focused only on investigating the prevalence of depression and anxiety.…”

Section: Discussionmentioning

confidence: 99%

“…This difference can be attributed to the fact that Khaustova et al . [ 20 ] conducted their study before the onset of the second wave of the pandemic in Ukraine.…”

Section: Discussionmentioning

confidence: 99%

“…However, these rates were higher than those reported in the abovementioned study, which were 19.8% and 18.5% for moderate-to-severe depression and anxiety, respectively. This difference can be attributed to the fact that Khaustova et al [20] conducted their study before the onset of the second wave of the pandemic in Ukraine.…”

Section: Financial Supportmentioning

confidence: 97%

See 2 more Smart Citations

Depression, anxiety, stress and trauma-related symptoms and their association with perceived social support in medical professionals during the COVID-19 pandemic in Ukraine

Martsenkovskyi¹,

Babych²,

Martsenkovska³

et al. 2022

ppn

View full text Add to dashboard Cite

Purpose: In a public health crisis medical professionals face immense psychological tension that leads to onset of negative mental health outcomes. We aimed to estimate the self-reported level of posttraumatic, anxiety, depression, and stress-related symptoms and their association with the level of perceived social support among healthcare professionals during the coronavirus (COVID-19) pandemic in Ukraine. Methods: A cross-sectional web-based survey conducted during the second wave of the pandemic involved 330 participants. Mental health variables were assessed via the Depression Anxiety Stress Scale (DASS-21) and PTSD Checklist for DSM-5 (PCL-5). The level of perceived social support was assessed via the Multidimensional Scale of Perceived Social Support (MSPSS). Results:The DASS-21 median score was 42.0 (IQR = 28.0-56.0), with 50.5% of respondents reporting moderate-to-severe depressive symptoms; 55.4% had moderate-to-severe anxiety levels; 42.4% had moderate-to-severe stress levels. The PCL-5 median score was 21.0 (IQR = 12.0-32.0), with 20% of the participants meeting the full criteria for PTSD. The MSPSS median score was 5.3 (IQR = 4.3-6.1), with 61.8% of the participants reporting high, 29.4% medium, and 8.8% low levels of social support, respectively. Logistic analysis revealed that being a younger person, female, having had previous exposure to COVID-19, working in inpatient facilities with COVID patients, and experiencing a lower level of social support were significant risk factors for the onset of mental disorders. Almost 75% of participants exhibited low-to-moderate adherence to psychological/psychiatric care. Conclusions: Health professionals working with COVID patients need to be screened for mental disorders. A campaign aimed at achieving the de-stigmatization of mental care is required.

show abstract

Section: Discussionmentioning

confidence: 99%

“…This difference can be attributed to the fact that Khaustova et al . [ 20 ] conducted their study before the onset of the second wave of the pandemic in Ukraine.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Depression, anxiety, stress and trauma-related symptoms and their association with perceived social support in medical professionals during the COVID-19 pandemic in Ukraine

Martsenkovskyi¹,

Babych²,

Martsenkovska³

et al. 2022

ppn

View full text Add to dashboard Cite

show abstract

Фармакотерапия Психических Расстройств, Ассоциированных С COVID-19

Khaustova

Чабан

2021

Психиатрия

View full text Add to dashboard Cite

Нарушениям психического здоровья, тесно связанным с COVID-19 на биологическом, психологическом и социальном уровнях, в настоящее время уделяется все больше и больше внимания. Психические и поведенческие расстройства могут быть проявлениями или осложнениями острого COVID-19, такими как острые психотические расстройства, чаще в виде гиперактивного делирия, или нарушения когнитивного функционирования, тревожные расстройства, нарушения сна, депрессия, суицидные попытки. Период постковида также представлен большим спектром психических расстройств, когда на первый план выступают когнитивные нарушения, тревожно-депрессивные расстройства и ПТСР.Проблема ранней диагностики и комплексной терапии психических расстройств, ассоциированных с COVID-19 на всех этапах течения этого заболевания, может быть успешно решена с использованием холистического психосоматического подхода. Медико-психологическое сопровождение и консультативная психиатрическая помощь осуществляются преимущественно в режиме телемедицины. Назначение психотропных препаратов обязательно должно учитывать риск лекарственных взаимодействий: лопинавир/ритонавир, хлорохин/гидрохлорохин и антибиотики часто дают потенциально опасные комбинации с психотропными препаратами в терапии острого COVID-19. В то же время ремдесивир, фавипиравир, тоцилизумаб, барицитиниб и анакинра могут использоваться одновременно с психотропными средствами без значимого риска лекарственного взаимодействия (за исключением гематологического риска при применении клозапина и барицитиниба).В статье представлены международные и национальные рекомендации по выбору наиболее эффективной терапии психических расстройств (антипсихотиков, антидепрессантов, тимостабилизаторов и анксиолитиков) в период острого COVID-19 с указанием доз и режима приема. Также даны рекомендации по менеджменту последствий COVID-19 с позиций доказательной медицины. Mental health disorders are closely related to COVID-19 at the biological, psychological, and social levels, and they are receiving more and more attention now. Mental and behavioral disorders may be the manifestations or complications of acute COVID-19, such as acute psychotic disorders, more often in the form of hyperactive delirium, cognitive impairment, anxiety disorders, sleep disorders, depression, and suicide attempts. The post-Covid period is also represented by a wide range of mental disorders, when cognitive impairment, anxiety, depression, and PTSD come to the fore.The problem of early diagnosis and complex therapy of mental disorders associated with COVID-19 at all stages of the disease can be successfully solved using a holistic psychosomatic approach. Medical and psychological support and counseling psychiatric care are provided mainly in the mode of telemedicine. When prescribing psychotropic drugs, the doctor should take into account the risk of drug interactions: lopinavir/ritonavir, chloroquine/hydroxychloroquine, and antibiotics often give potentially dangerous combinations with psychotropic drugs in the treatment of acute COVID-19. At the same time, remdesivir, favipiravir, tocilizumab, baricitinib, and anakinra can be used concomitantly with psychotropic drugs without significant risk of drug interaction (except for the hematological risk with clozapine and baricitinib).The article presents international and national recommendations for the selection of the most effective therapy for mental disorders (antipsychotics, antidepressants, thymostabilizers, and anxiolytics) during acute COVID-19, indicating the doses and mode of administration. The recommendations for the management of the consequences of COVID-19 from the standpoint of evidence-based medicine are also given.

show abstract

P.655 Resilience and emotional state of healthcare professionals in Ukraine during lockdown: a pilot study

Cited by 2 publications

References 2 publications

Depression, anxiety, stress and trauma-related symptoms and their association with perceived social support in medical professionals during the COVID-19 pandemic in Ukraine

Depression, anxiety, stress and trauma-related symptoms and their association with perceived social support in medical professionals during the COVID-19 pandemic in Ukraine

Фармакотерапия Психических Расстройств, Ассоциированных С COVID-19

Contact Info

Product

Resources

About